Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital Heidelberg
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)